Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 945

1.

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, Walsh M, Guccione A, Cannan J, Heller H, Basgoz N, Klibanski A.

J Clin Endocrinol Metab. 1996 Nov;81(11):4051-8.

PMID:
8923860
2.

Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.

Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A.

J Clin Endocrinol Metab. 1998 Dec;83(12):4251-6.

PMID:
9851759
3.

Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.

Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A.

J Clin Endocrinol Metab. 1997 May;82(5):1332-7. Erratum in: J Clin Endocrinol Metab 1997 Oct;82(10):3360.

PMID:
9141512
4.

Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome.

Grinspoon S, Corcoran C, Rosenthal D, Stanley T, Parlman K, Costello M, Treat M, Davis S, Burrows B, Basgoz N, Klibanski A.

J Clin Endocrinol Metab. 1999 Jan;84(1):201-6.

PMID:
9920084
5.

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.

J Clin Endocrinol Metab. 2000 Jan;85(1):35-41.

PMID:
10634360
6.

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

Ann Intern Med. 1998 Jul 1;129(1):18-26.

PMID:
9652995
7.

Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects.

Hayes VY, Urban RJ, Jiang J, Marcell TJ, Helgeson K, Mauras N.

J Clin Endocrinol Metab. 2001 May;86(5):2211-9.

PMID:
11344229
8.

Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.

Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK.

J Clin Endocrinol Metab. 2001 May;86(5):2020-6.

PMID:
11344201
9.

Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting.

Huang JS, Wilkie SJ, Sullivan MP, Grinspoon S.

J Clin Endocrinol Metab. 2001 Aug;86(8):3533-9.

PMID:
11502775
10.

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.

Strawford A, Barbieri T, Neese R, Van Loan M, Christiansen M, Hoh R, Sathyan G, Skowronski R, King J, Hellerstein M.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):137-46.

PMID:
10048900
12.

Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.

Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S.

J Clin Endocrinol Metab. 1998 Aug;83(8):2717-25.

PMID:
9709937
13.

Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.

Grinspoon S, Corcoran C, Stanley T, Baaj A, Basgoz N, Klibanski A.

J Clin Endocrinol Metab. 2000 Jan;85(1):60-5.

PMID:
10634364
14.

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.

Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK.

JAMA. 1999 Apr 14;281(14):1282-90.

PMID:
10208143
15.

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.

J Clin Endocrinol Metab. 1998 Sep;83(9):3155-62.

PMID:
9745419
16.

Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

Vermeulen A, Kaufman JM, Giagulli VA.

J Clin Endocrinol Metab. 1996 May;81(5):1821-6.

PMID:
8626841
17.

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A.

J Clin Endocrinol Metab. 1996 Dec;81(12):4358-65.

PMID:
8954042
18.

Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.

Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M; ACTG 313 Study Team.

J Clin Endocrinol Metab. 2007 Feb;92(2):563-70. Epub 2006 Nov 7.

PMID:
17090640
19.

Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.

Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S.

Clin Infect Dis. 2000 Nov;31(5):1240-4. Epub 2000 Nov 2.

PMID:
11073758
20.

Serum hormones in men with human immunodeficiency virus-associated wasting.

Dobs AS, Few WL 3rd, Blackman MR, Harman SM, Hoover DR, Graham NM.

J Clin Endocrinol Metab. 1996 Nov;81(11):4108-12.

PMID:
8923868

Supplemental Content

Support Center